Pegloticase is given as an intravenous infusion every two weeks, and has been found to reduce uric acid levels in this population.
Peglotikaza se primjenjuje intravenoznom infuzijom svaka dva tjedna, i dokazano smanjuje razinu mokraćne kiseline u ovoj populaciji.